Literature DB >> 10372667

Therapeutic controversy: Screening for postpartum thyroiditis.

N Amino1, H Tada, Y Hidaka, L M Crapo, A Stagnaro-Green.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10372667     DOI： 10.1210/jcem.84.6.5751-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Soluble CD4 concentrations predict relapse of post-partum thyroiditis.

Authors:  C Balázs; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

2.  The sardinian autoimmunity study. 4. Thyroid and islet cell autoantibodies in sardinian pregnant women at delivery: a cross-sectional study.

Authors:  A Olivieri; G Pinna; A Lai; F Velluzzi; A Pilo; F Atzeni; G Guaita; R Cirillo; M Sorcini; S Carta; G F Bottazzo; S Mariotti
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

Review 3.  Screening for thyroid disease in pregnancy.

Authors:  J H Lazarus; L D K E Premawardhana
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

4.  Age as a predictor of recurrent hypothyroidism in patients with post-partum thyroid dysfunction.

Authors:  F Azizi
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

5.  Post-partum thyroiditis in a mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery.

Authors:  M Kita; D G Goulis; A Avramides
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

6.  Thyroid peroxidase antibody and screening for postpartum thyroid dysfunction.

Authors:  Mohamed A Adlan; Lakdasa D Premawardhana
Journal:  J Thyroid Res       Date:  2011-07-10

7.  Development of postpartum Graves' disease and type 1 diabetes after delivery in a patient with gestational diabetes.

Authors:  Mayumi Negishi; Kenju Shimomura; Peter Proks; Rieko Nakahara; Masami Murakami; Yohnosuke Shimomura; Isao Kobayashi
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.